THANK YOU FOR SUBSCRIBING
To survive and thrive, it is more essential than ever for pharmaceutical companies to explore and invest in technology innovations.
FREMONT, CA: Adopting cutting-edge technologies can play a key role in the digital revolution of the pharmaceutical industry. But bagging this opportunity requires the right initiatives. Technologies including Artificial Intelligence, Machine Learning, AR-VR, Digital Apps, The Internet of Things, 3D printers are among the innovations that are starting to transform theGerman pharmaceutical industry. Pharma executives, researchers, innovators, and lawmakers in Germany are well aware of the disruptive potential of these digital initiatives. Here are some trending technologies that are already changing and will contribute more to reshape Germany’s pharmaceutical industry.
Artificial intelligence and machine learning are a big thing for the German pharmaceutical industry. AI is already being used for conducting repetitive tasks such as data entry, lab test analyses, data management, data analysis to identify errors or inefficiencies, medication management monitored by AI-based systems, and many more. ML is being used in disease identification and diagnosis, radiology and radiotherapy planning, clinical trial research, personalized medicine, rare disease identification, and new drug invention, etc.
Health Mobile Applications
Pharma companies in Germany re lately realizing that it is not enough anymore if they are only producing and developing drugs. The recent trends in the sector show that they have to go beyond the physical appearance of medicines. These are called ‘around the pill’ digital offerings; it includes digital health mobile apps, devices, or services that could be prescribed by a doctor or bundled with a medicine.
Augmented and Virtual Reality (AR-VR)
AR-VR has many things that contribute to Germany’s pharmaceutical industry. With their ability to create a virtual world, AR and VR are promising technologies that can cater to a wide range of needs of the pharmaceutical industry. VR can enhance the efficiency of the pre-development phases of medicine by enabling researchers to better visualize the interactions and thus redesign molecules according to specifications.